Ichikawa Tomotsugu, Wakisaka Akiko, Daido Shigeru, Takao Soichiro, Tamiya Takashi, Date Isao, Koizumi Shoichi, Niida Yo
Department of Neurological Surgery, Okayama University Graduate School of Medicine and Dentistry, Japan.
J Mol Diagn. 2005 Oct;7(4):544-9. doi: 10.1016/S1525-1578(10)60586-7.
Subependymal giant cell astrocytoma (SEGA) is a unique brain tumor arising in tuberous sclerosis complex (TSC), an autosomal dominant inherited phacomatosis. There are several case reports of solitary SEGA without any other manifestations of TSC. Usually these cases are thought to be forme fruste of TSC due to somatic mosaicism. However, no previous reports have used molecular methodology to fully investigate mutations in TSC genes or the possibility of somatic mosaicism. Here, we report a 20-year-old woman with a brain tumor. Pathological diagnosis was consistent with SEGA, but comprehensive clinical screening found no other lesions indicative of TSC. Molecular analysis of the tumor revealed loss of heterozygosity and allelic mutation (5228G>A, R1743Q) of TSC2. To detect the small fraction of mosaic mutation in somatic cells, we developed a highly sensitive new method: triple-nested polymerase chain reaction-restriction fragment length polymorphism. The identical TSC2 missense mutation was not detected in any other tissues from the same patient, including peripheral blood, buccal mucosa, urinary sediment, nail, and hair. According to these results, this patient should be considered as having SEGA that developed from two somatic hit mutations in TSC2, rather than being a TSC2 patient with a very small fraction of somatic mosaicism.
室管膜下巨细胞星形细胞瘤(SEGA)是一种起源于结节性硬化症(TSC)的独特脑肿瘤,TSC是一种常染色体显性遗传性错构瘤病。有几例孤立性SEGA的病例报告,患者无TSC的任何其他表现。通常这些病例被认为是由于体细胞镶嵌现象导致的TSC不完全型。然而,此前尚无报告使用分子方法全面研究TSC基因中的突变或体细胞镶嵌现象的可能性。在此,我们报告一名患有脑肿瘤的20岁女性。病理诊断与SEGA一致,但全面的临床筛查未发现其他提示TSC的病变。对肿瘤的分子分析显示TSC2存在杂合性缺失和等位基因突变(5228G>A,R1743Q)。为了检测体细胞中少量的镶嵌突变,我们开发了一种高度灵敏的新方法:三重巢式聚合酶链反应-限制性片段长度多态性。在同一患者的任何其他组织中,包括外周血、颊黏膜、尿沉渣、指甲和头发,均未检测到相同的TSC2错义突变。根据这些结果,该患者应被视为由TSC2中的两个体细胞打击突变发展而来的SEGA,而非具有极少量体细胞镶嵌现象的TSC2患者。